Page 108 - 南京医科大学自然版

第44卷第5期
·696 · 南 京 医 科 大 学 学 报 2024年5月

transferase M3 is associated with glycolysis in intrinsic te⁃ cer，2013，108（10）：2005-2012
mozolomide ⁃ resistant glioblastoma multiforme cells［J］. ［53］YANG K，NIU L，BAI Y J，et al. Glioblastoma：targeting
Int J Mol Sci，2021，22（13）：7080 the autophagy in tumorigenesis［J］. Brain Res Bull，2019，
［41］QIAN Y F，DING P，XU J，et al. CCL2 activates AKT sig⁃ 153：334-340
naling to promote glycolysis and chemoresistance in glio⁃ ［54］高健成，陆晨飞，张梓枫，等. 胶质瘤干细胞来源的外泌
ma cells［J］. Cell Biol Int，2022，46（5）：819-828 体促进胶质瘤恶性进展［J］. 南京医科大学学报（自然
［42］BI J F，KHAN A，TANG J，et al. Targeting glioblastoma 科学版），2022，42（12）：1658-1663
signaling and metabolism with a re⁃purposed brain⁃pene⁃ ［55］王翠蓉，王义俊，张爱霞，等. 肿瘤微环境对脑胶质瘤血
trant drug［J］. Cell Rep，2021，37（5）：109957 管拟态形成的影响及药理学意义［J］. 南京医科大学学
［43］MAIMÓ⁃BARCELÓ A，MARTÍN⁃SAIZ L，FERNÁNDEZ 报（自然科学版），2023，43（1）：107-112
J A，et al. Polyunsaturated fatty acid⁃enriched lipid finger⁃ ［56］MENG L T，WANG C R，LU Y P，et al. Targeted regula⁃
print of glioblastoma proliferative regions is differentially tion of blood⁃brain barrier for enhanced therapeutic effi⁃
regulated according to glioblastoma molecular subtype［J］. ciency of hypoxia ⁃ modifier nanoparticles and immune
Int J Mol Sci，2022，23（6）：2949 checkpoint blockade antibodies for glioblastoma［J］. ACS
［44］LIN H Y，LIAO K H，KO C Y，et al. 17β⁃estradiol induces Appl Mater Interfaces，2021，13（10）：11657-11671
temozolomide resistance through NRF2 ⁃ mediated redox ［57］ZHANG X N，YANG K D，CHEN C，et al. Pericytes aug⁃
homeostasis in glioblastoma［J］. Free Radic Biol Med， ment glioblastoma cell resistance to temozolomide through
2021，172：430-440 CCL5⁃CCR5 paracrine signaling［J］. Cell Res，2021，31
［45］YASUMOTO Y，MIYAZAKI H，VAIDYAN L K，et al. （10）：1072-1087
Inhibition of fatty acid synthase decreases expression of ［58］HUANG M G，ZHANG D，WU J Y，et al. Wnt⁃mediated
stemness markers in glioma stem cells［J］. PLoS One， endothelial transformation into mesenchymal stem cell ⁃
2016，11（1）：e0147717 like cells induces chemoresistance in glioblastoma［J］.
［46］SHIM J K，CHOI S，YOON S J，et al. Etomoxir，a carni⁃ Sci Transl Med，2020，12（532）：eaay7522
tine palmitoyltransferase 1 inhibitor，combined with temo⁃ ［59］ZHANG G，TAO X，JI B W，et al. Hypoxia⁃driven M2⁃po⁃
zolomide reduces stemness and invasiveness in patient ⁃ larized macrophages facilitate cancer aggressiveness and
derived glioblastoma tumorspheres［J］. Cancer Cell Int， temozolomide resistance in glioblastoma［J］. Oxid Med
2022，22（1）：309 Cell Longev，2022，2022：1614336
［47］GALLI R，BINDA E，ORFANELLI U，et al. Isolation and ［60］GOLEBIEWSKA A，HAU A C，OUDIN A，et al. Patient⁃
characterization of tumorigenic，stem⁃like neural precur⁃ derived organoids and orthotopic xenografts of primary
sors from human glioblastoma［J］. Cancer Res，2004，64 and recurrent gliomas represent relevant patient avatars
（19）：7011-7021 for precision oncology［J］. Acta Neuropathol，2020，140
［48］ECKERDT F，PLATANIAS L C. Emerging role of glioma （6）：919-949
stem cells in mechanisms of therapy resistance［J］. Can⁃ ［61］WANG K，KIEVIT F M，CHIARELLI P A，et al. siRNA
cers，2023，15（13）：3458 nanoparticle suppresses drug⁃resistant gene and prolongs
［49］FANFONE D，IDBAIH A，MAMMI J，et al. Profiling anti⁃ survival in an orthotopic glioblastoma xenograft mouse
apoptotic BCL ⁃ xL protein expression in glioblastoma model［J］. Adv Funct Mater，2021，31（6）：2007166
tumorspheres［J］. Cancers，2020，12（10）：2853 ［62］LIN K，GUEBLE S E，SUNDARAM R K，et al. Mechanism
［50］ZHANG Y，WANG S X，MA J W，et al. EGCG inhibits ⁃based design of agents that selectively target drug⁃resis⁃
properties of glioma stem⁃like cells and synergizes with tant glioma［J］. Science，2022，377（6605）：502-511
temozolomide through downregulation of P ⁃ glycoprotein ［63］OU M T，CHO H Y，FU J，et al. Inhibition of autophagy
inhibition［J］. J Neurooncol，2015，121（1）：41-52 and induction of glioblastoma cell death by NEO214，a
［51］URIBE D，TORRES Á，ROCHA J D，et al. Multidrug re⁃ perillyl alcohol⁃rolipram conjugate［J］. Autophagy，2023，
sistance in glioblastoma stem⁃like cells：role of the hypoxic 19（12）：3169-3188
microenvironment and adenosine signaling［J］. Mol ［64］GUO G，GONG K，PULIYAPPADAMBA V T，et al. Effi⁃
Aspects Med，2017，55：140-151 cacy of EGFR plus TNF inhibition in a preclinical model
［52］MARTÍN V，SANCHEZ⁃SANCHEZ A M，HERRERA F， of temozolomide⁃resistant glioblastoma［J］. Neuro Oncol，
et al. Melatonin ⁃ induced methylation of the ABCG2/ 2019，21（12）：1529-1539
BCRP promoter as a novel mechanism to overcome multi⁃ ［65］DESJARDINS A，GROMEIER M，HERNDON J E，et al.
drug resistance in brain tumour stem cells［J］. Br J Can⁃ Recurrent glioblastoma treated with recombinant poliovi⁃